Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients

Y. Maehara, S. Tomisaki, S. Oda, Y. Sakaguchi, Y. Ichiyoshi, K. Sugimachi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Lymph node metastasis is a risk factor for the occurrence of peritoneal dissemination and liver metastasis in patients with gastric cancer. We analysed data on 893 Japanese patients with serosally invasive gastric cancer, with respect to the relation between lymph node metastasis and peritoneal dissemination or liver metastasis. All these patients were treated in our clinics. Lymph node metastasis was evident in 746 patients, and in these patients the tumors were larger, lymphatic and vascular involvement were prominent and rates of peritoneal dissemination and liver metastasis were higher. In 147 patients with no evidence of lymph node metastasis, peritoneal dissemination was seen in 3.4% of cases and there was no liver metastasis. In cases of peritoneal dissemination and in those with liver metastasis, the rate of lymphatic involvement was higher than when there was vascular involvement. Peritoneal dissemination and liver metastasis are likely to be concomitant with lymph node metastasis in cases of serosally invasive gastric cancer. It seems apparent that lymphatic spread leads to peritoneal dissemination and liver metastasis in patients with gastric cancer.

Original languageEnglish
Pages (from-to)2755-2757
Number of pages3
JournalAnticancer research
Volume14
Issue number6 B
Publication statusPublished - Dec 1 1994

Fingerprint

Stomach Neoplasms
Neoplasm Metastasis
Liver
Lymph Nodes
Blood Vessels
Lymphatic Metastasis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Maehara, Y., Tomisaki, S., Oda, S., Sakaguchi, Y., Ichiyoshi, Y., & Sugimachi, K. (1994). Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. Anticancer research, 14(6 B), 2755-2757.

Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. / Maehara, Y.; Tomisaki, S.; Oda, S.; Sakaguchi, Y.; Ichiyoshi, Y.; Sugimachi, K.

In: Anticancer research, Vol. 14, No. 6 B, 01.12.1994, p. 2755-2757.

Research output: Contribution to journalArticle

Maehara, Y, Tomisaki, S, Oda, S, Sakaguchi, Y, Ichiyoshi, Y & Sugimachi, K 1994, 'Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients', Anticancer research, vol. 14, no. 6 B, pp. 2755-2757.
Maehara Y, Tomisaki S, Oda S, Sakaguchi Y, Ichiyoshi Y, Sugimachi K. Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. Anticancer research. 1994 Dec 1;14(6 B):2755-2757.
Maehara, Y. ; Tomisaki, S. ; Oda, S. ; Sakaguchi, Y. ; Ichiyoshi, Y. ; Sugimachi, K. / Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. In: Anticancer research. 1994 ; Vol. 14, No. 6 B. pp. 2755-2757.
@article{28cf0002c6044ee4939ad3532af5376d,
title = "Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients",
abstract = "Lymph node metastasis is a risk factor for the occurrence of peritoneal dissemination and liver metastasis in patients with gastric cancer. We analysed data on 893 Japanese patients with serosally invasive gastric cancer, with respect to the relation between lymph node metastasis and peritoneal dissemination or liver metastasis. All these patients were treated in our clinics. Lymph node metastasis was evident in 746 patients, and in these patients the tumors were larger, lymphatic and vascular involvement were prominent and rates of peritoneal dissemination and liver metastasis were higher. In 147 patients with no evidence of lymph node metastasis, peritoneal dissemination was seen in 3.4{\%} of cases and there was no liver metastasis. In cases of peritoneal dissemination and in those with liver metastasis, the rate of lymphatic involvement was higher than when there was vascular involvement. Peritoneal dissemination and liver metastasis are likely to be concomitant with lymph node metastasis in cases of serosally invasive gastric cancer. It seems apparent that lymphatic spread leads to peritoneal dissemination and liver metastasis in patients with gastric cancer.",
author = "Y. Maehara and S. Tomisaki and S. Oda and Y. Sakaguchi and Y. Ichiyoshi and K. Sugimachi",
year = "1994",
month = "12",
day = "1",
language = "English",
volume = "14",
pages = "2755--2757",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients

AU - Maehara, Y.

AU - Tomisaki, S.

AU - Oda, S.

AU - Sakaguchi, Y.

AU - Ichiyoshi, Y.

AU - Sugimachi, K.

PY - 1994/12/1

Y1 - 1994/12/1

N2 - Lymph node metastasis is a risk factor for the occurrence of peritoneal dissemination and liver metastasis in patients with gastric cancer. We analysed data on 893 Japanese patients with serosally invasive gastric cancer, with respect to the relation between lymph node metastasis and peritoneal dissemination or liver metastasis. All these patients were treated in our clinics. Lymph node metastasis was evident in 746 patients, and in these patients the tumors were larger, lymphatic and vascular involvement were prominent and rates of peritoneal dissemination and liver metastasis were higher. In 147 patients with no evidence of lymph node metastasis, peritoneal dissemination was seen in 3.4% of cases and there was no liver metastasis. In cases of peritoneal dissemination and in those with liver metastasis, the rate of lymphatic involvement was higher than when there was vascular involvement. Peritoneal dissemination and liver metastasis are likely to be concomitant with lymph node metastasis in cases of serosally invasive gastric cancer. It seems apparent that lymphatic spread leads to peritoneal dissemination and liver metastasis in patients with gastric cancer.

AB - Lymph node metastasis is a risk factor for the occurrence of peritoneal dissemination and liver metastasis in patients with gastric cancer. We analysed data on 893 Japanese patients with serosally invasive gastric cancer, with respect to the relation between lymph node metastasis and peritoneal dissemination or liver metastasis. All these patients were treated in our clinics. Lymph node metastasis was evident in 746 patients, and in these patients the tumors were larger, lymphatic and vascular involvement were prominent and rates of peritoneal dissemination and liver metastasis were higher. In 147 patients with no evidence of lymph node metastasis, peritoneal dissemination was seen in 3.4% of cases and there was no liver metastasis. In cases of peritoneal dissemination and in those with liver metastasis, the rate of lymphatic involvement was higher than when there was vascular involvement. Peritoneal dissemination and liver metastasis are likely to be concomitant with lymph node metastasis in cases of serosally invasive gastric cancer. It seems apparent that lymphatic spread leads to peritoneal dissemination and liver metastasis in patients with gastric cancer.

UR - http://www.scopus.com/inward/record.url?scp=0028670951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028670951&partnerID=8YFLogxK

M3 - Article

C2 - 7872713

AN - SCOPUS:0028670951

VL - 14

SP - 2755

EP - 2757

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -